Physician profile
Eugene M Lee
NPI 1306939475
$1,412.20
in general payments reported to CMS, 2019-2025
15 companies · $98.55 in 2025
The $98.55 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $122 · 2021: $373 · 2022: $309 · 2023: $258 · 2024: $54.07 · 2025: $98.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $425.64 | 2020-2022 | |
| Lilly USA, LLC | $317.77 | 2019-2024 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $110.69 | 2019-2024 | Breztri, Farxiga |
| Novo Nordisk INC | $104.02 | 2019-2023 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $70.12 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.69 | 2019 | |
| Pfizer INC. | $51.98 | 2019-2021 | |
| Stryker Corporation | $51.92 | 2025 | Aequalis Perform Reversed, Aequalis Flex Revive, Aequalis Perform |
| Abbott Laboratories | $46.63 | 2025 | Freestyle Libre 3 |
| Amgen INC. | $44.80 | 2019-2020 | |
| Radius Health, INC. | $43.78 | 2019-2020 | |
| Cook Medical LLC | $32.75 | 2022 | |
| Genentech USA, INC. | $21.31 | 2021 | |
| Amneal Pharmaceuticals LLC | $20.56 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.